LogicBio Therapeutics (LOGC) PT Lowered to $2 at JMP Securities
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 9
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 9
Join SI Premium – FREE
JMP Securities analyst Silvan Tuerkcan lowered the price target on LogicBio Therapeutics (NASDAQ: LOGC) to $2.00 (from $16.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- Barclays Downgrades Murphy Oil Corp. (MUR) to Underweight
- NKT A/S (NKT:DC) PT Lowered to DKK916 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
